Putnam Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Putnam Investments’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-63,732	Closed	-$2.15M	–	1589
2014 Q4	$2.15M	Sell	63,732 -14,126	-18%	-$499K	﹤0.01%	1007
2014 Q3	$2.73M	Sell	77,858 -428,575	-85%	-$14.7M	0.01%	946
2014 Q2	$16.6M	Buy	506,433 +67,637	+15%	+$2.31M	0.04%	361
2014 Q1	$16.2M	Buy	+438,796	New	+$16.1M	0.04%	368

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Putnam Investments's WX Position: Q1 2015 in Review

Putnam Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 63,732 shares — an estimated $2.15M sold.

Putnam Investments first reported a position in WX in Q1 2014 and held it in 4 quarters. The position peaked at $16.6M in Q2 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Putnam Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Putnam Investments sold 63,732 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $2.15M.
Putnam Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 4 quarters.
Putnam Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $16.6M in Q2 2014.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Putnam Investments's 13F filing for Q1 2015, filed 15 May 2015.